What's in Polish Adult Leukemia Group's pipeline?

Polish Adult Leukemia Group has 4 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Polish Adult Leukemia Group's portfolio?

Top competitors by shared drug class: Children's Cancer Group, China, Asan Medical Center, Sun Yat-sen University, Zhejiang Cancer Hospital, Agendia.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/polish-adult-leukemia-group.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Polish Adult Leukemia Group — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Polish Adult Leukemia Group pipeline: 0 marketed, 0 filed, 4 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
B arm (DAC)	B arm (DAC)	phase 3	Combination chemotherapy regimen		Oncology
B arm (FLAG-IDA)	B arm (FLAG-IDA)	phase 3	Chemotherapy combination regimen		Oncology
A arm (DA-90)	A arm (DA-90)	phase 3	CD19-targeting monoclonal antibody	CD19	Oncology
A arm (CLAG-M)	A arm (CLAG-M)	phase 3	Multi-agent chemotherapy regimen		Oncology

Therapeutic area mix

Oncology · 4

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Children's Cancer Group, China · 3 shared drug classes
Asan Medical Center · 2 shared drug classes
Sun Yat-sen University · 2 shared drug classes
Zhejiang Cancer Hospital · 2 shared drug classes
Agendia · 1 shared drug class
AstraZeneca · 1 shared drug class
Amgen · 1 shared drug class
Beijing Friendship Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Polish Adult Leukemia Group:

Cite this brief

Drug Landscape (2026). Polish Adult Leukemia Group — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/polish-adult-leukemia-group. Accessed 2026-05-17.